211 related articles for article (PubMed ID: 33495337)
1. Targeting OCT3 attenuates doxorubicin-induced cardiac injury.
Huang KM; Zavorka Thomas M; Magdy T; Eisenmann ED; Uddin ME; DiGiacomo DF; Pan A; Keiser M; Otter M; Xia SH; Li Y; Jin Y; Fu Q; Gibson AA; Bonilla IM; Carnes CA; Corps KN; Coppola V; Smith SA; Addison D; Nies AT; Bundschuh R; Chen T; Lustberg MB; Wang J; Oswald S; Campbell MJ; Yan PS; Baker SD; Hu S; Burridge PW; Sparreboom A
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495337
[TBL] [Abstract][Full Text] [Related]
2. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
[TBL] [Abstract][Full Text] [Related]
3. MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice.
Fan D; Chen HB; Leng Y; Yang SJ
Curr Med Sci; 2022 Feb; 42(1):48-55. PubMed ID: 35089495
[TBL] [Abstract][Full Text] [Related]
4. Organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter in the placenta and fetal tissues: expression profile and fetus protective role at different stages of gestation.
Ahmadimoghaddam D; Zemankova L; Nachtigal P; Dolezelova E; Neumanova Z; Cerveny L; Ceckova M; Kacerovský M; Micuda S; Staud F
Biol Reprod; 2013 Mar; 88(3):55. PubMed ID: 23303678
[TBL] [Abstract][Full Text] [Related]
5. Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model.
Zhou ZY; Wan LL; Yang QJ; Han YL; Li D; Lu J; Guo C
Toxicol Lett; 2016 Sep; 259():124-132. PubMed ID: 27491883
[TBL] [Abstract][Full Text] [Related]
6. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
[TBL] [Abstract][Full Text] [Related]
7. miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicity.
Pan JA; Tang Y; Yu JY; Zhang H; Zhang JF; Wang CQ; Gu J
Cell Death Dis; 2019 Sep; 10(9):668. PubMed ID: 31511497
[TBL] [Abstract][Full Text] [Related]
8. Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue.
Otter M; Csader S; Keiser M; Oswald S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008681
[TBL] [Abstract][Full Text] [Related]
9. Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity.
Magdy T; Jouni M; Kuo HH; Weddle CJ; Lyra-Leite D; Fonoudi H; Romero-Tejeda M; Gharib M; Javed H; Fajardo G; Ross CJD; Carleton BC; Bernstein D; Burridge PW
Circulation; 2022 Jan; 145(4):279-294. PubMed ID: 34874743
[TBL] [Abstract][Full Text] [Related]
10. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
11. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
[TBL] [Abstract][Full Text] [Related]
12. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
[TBL] [Abstract][Full Text] [Related]
13. Proanthocyanidin alleviates doxorubicin-induced cardiac injury by inhibiting NF-kB pathway and modulating oxidative stress, cell cycle, and fibrogenesis.
Sadek KM; Mahmoud SFE; Zeweil MF; Abouzed TK
J Biochem Mol Toxicol; 2021 Apr; 35(4):e22716. PubMed ID: 33484087
[TBL] [Abstract][Full Text] [Related]
14. Telomerase therapy attenuates cardiotoxic effects of doxorubicin.
Chatterjee S; Hofer T; Costa A; Lu D; Batkai S; Gupta SK; Bolesani E; Zweigerdt R; Megias D; Streckfuss-Bömeke K; Brandenberger C; Thum T; Bär C
Mol Ther; 2021 Apr; 29(4):1395-1410. PubMed ID: 33388418
[TBL] [Abstract][Full Text] [Related]
15. Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.
Gupta SK; Garg A; Bär C; Chatterjee S; Foinquinos A; Milting H; Streckfuß-Bömeke K; Fiedler J; Thum T
Circ Res; 2018 Jan; 122(2):246-254. PubMed ID: 29133306
[TBL] [Abstract][Full Text] [Related]
16. Deletion of organic cation transporter Oct3 promotes hepatic fibrosis via upregulation of TGFβ.
Vollmar J; Kim YO; Marquardt JU; Becker D; Galle PR; Schuppan D; Zimmermann T
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G195-G202. PubMed ID: 31241979
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of miR378* on doxorubicin-induced cardiomyocyte injury via calumenin.
Wang Y; Cui X; Wang Y; Fu Y; Guo X; Long J; Wei C; Zhao M
J Cell Physiol; 2018 Oct; 233(10):6344-6351. PubMed ID: 29665007
[TBL] [Abstract][Full Text] [Related]
18. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
[TBL] [Abstract][Full Text] [Related]
19. Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling.
Verheijen M; Schrooders Y; Gmuender H; Nudischer R; Clayton O; Hynes J; Niederer S; Cordes H; Kuepfer L; Kleinjans J; Caiment F
Toxicol Lett; 2018 Sep; 294():184-192. PubMed ID: 29803840
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Cardiac Maintenance and Survival Factor FGF-16 Gene Is Regulated by Csx/Nkx2.5 and Is an Early Target of Doxorubicin Cardiotoxicity.
Wang J; Jin Y; Cattini PA
DNA Cell Biol; 2017 Feb; 36(2):117-126. PubMed ID: 27929351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
